The Migraine Research Foundation is the only organization whose sole purpose is to raise funds for innovative scientific research to further the understanding of the causes and mechanisms of migraine, to develop improvements in treatments for sufferers, and to find the cure.
Deadline for letter of intent: August 1, 2014Read More
The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide.
Deadline for Letter of Intent: September 19, 2014Read More
There are two parts of this SMRI program:
I. Regular Treatment Trials - The purpose of this program is to support the testing of medications to assess their efficacy for treating schizophrenia and bipolar disorder. SMRI is especially interested in supporting the testing of medications that are unlikely to be tested by pharmaceutical companies because they are not commercially profitable.
II. Special Treatment Trials and Drug Development - SMRI also supports special treatment trials and occasional drug development. Special treatment trials are usually multi-center trials that require more than $300,000 per year to carry out. Such trials are usually reserved for medications for which preliminary SMRI-supported trials have been promising.
Deadline: October 1, 2014Read More
Immunodeficiency Canada each fall annually requests proposals focused on research in primary immune deficiency (PI).
Deadline for Letter of Intent: September 26, 2014.Read More
The Saving tiny Hearts Society’s mission is to raise seed money for grossly under-funded, lifesaving grass roots research of congenital heart defects (CHD's).
Deadline: September 26, 2014Read More
Western researchers can consult Pivot, a comprehensive database of grant information.